Format

Send to:

Choose Destination
See comment in PubMed Commons below
Crit Care. 2006 Feb;10(1):115.

Choosing the right combination therapy in severe community-acquired pneumonia.

Author information

  • 1School of Medicine and Pharmacology, University of Western Australia, MRF Building, Royal Perth Hospital, GPO Box X2213, Perth 6847, Australia. waterer@cyllene.uwa.edu.au

Abstract

Recent studies have suggested that combination antibiotic therapy is preferable to monotherapy for severe community-acquired pneumonia (CAP). In this issue Mortensen and colleagues present retrospective data suggesting that combination therapy with a cephalosporin and a fluoroquinolone is inferior to combination therapy with a cephalosporin and a macrolide. Several mechanisms exist by which quinolones could be inferior to macrolides in combination therapy, so if these findings are confirmed by other groups they have significant implications for physicians treating patients with severe CAP.

PMID:
16469123
[PubMed - indexed for MEDLINE]
PMCID:
PMC1550800
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk